Siemens Healthineers launches brain health research portfolio with first biomarker assays now available

Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for 1. Every year, there are nearly 10 million new cases of dementia diagnosed worldwide2. Alzheimer’s disease is the most common, contributing to … Read more

How one man defied his genetic fate for nearly two decades

Scientists discovered a rare case of an Alzheimer’s gene carrier who remained symptom-free for 18 years beyond the expected onset, revealing potential genetic, environmental, and proteomic resilience factors. Study: Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia. Image Credit: Kateryna Kon / Shutterstock In a recent study in the journal Nature Medicine, … Read more

Gyros Protein Technologies Introduces New HEK293 HCP Type SN and CL Kit Reagents

Archyde New Kits ‍Enhance Detection of Host Cell Proteins in Biotherapeutics new kits Enhance Detection‍ of ⁣Host Cell Proteins ⁢in Biotherapeutics Ensuring the ⁣safety ​and efficacy of biotherapeutics requires meticulous‌ attention⁢ to detail throughout the progress process. One critical step‌ is the ⁢removal of host cell ⁣proteins⁣ (HCPs), which can⁤ trigger immune​ responses in patients … Read more

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit Reagents and Gyrolab HEK293 HCP Type CL Kit Reagents. Developed with antibodies from BioGenes GmbH, a global leader in host cell protein (HCP) assay development, the new kits … Read more